|
"Very well organised, covering hot topics and with ample opportunity for networking. A vibrant atmosphere"
Dr Hilde De Winter, Director, Clinical Development & Medical Affairs, Innogenetics
"I continue to find Phacilitate vaccine meetings to have strong speakers and agendas on a range of very timely topics"
Dr Ronald W. Ellis, Senior Vice President, R&D, AVANT Immunotherapeutics, Inc
“Excellent networking opportunity. Exactly the right size and a non-intimidating environment”
Dr Kelly McKee, Vice President, Public Health & Government Services, Quintiles Transnational Corp
“An excellent opportunity to meet influential people from the 'big 5', biotechs and non-profits”
Dr Hans Arvidsson, President, Eurocine Vaccines AB
|
"Outstanding – up-to-date and ideal for networking"
Dr Olav Zilian, Finance Analyst – Biotech, Helvea
"Excellent opportunity to connect with the vaccine industry’s key players and to network"
Dr Silke Fetzer, Head of Product Management, Cell Culture & Vaccine Operational Marketing, GE Healthcare
"Very good quality and mix of public/private sector speakers"
Peter Brazier, CEO, NewBiomed PIKA Pte Ltd
“Organizing staff has been wonderful. Flash drive with presentations is a great idea”
Dr Brendan Thomason, Analyst, Booz Allen Hamilton/National Center for Medical Intelligence
“Great conference. Well organized. Good balance of topics and speakers”
Dr Niranjan Y. Sardesai, Senior Vice President, Research & Development, VGX Pharmaceuticals, Inc
|
